(1 - 16 von 18
)
Data from Genzyme's Multiple Sclerosis Franchise Featured at AAN
www.finanznachrichten.de
Erin Pascal, + or. Sanofi Investor Relations Kristen Galfetti, +
Sanofi: Slowing of Brain Atrophy and Reductions in New MS Lesions...
www.globenewswire.com
Slowing of Brain Atrophy and Reductions in New Multiple Sclrosis Lesions Sustained at Three Years in Patients Treated with Genzyme's LemtradaTM
Genzyme Receives Complete Response Letter from FDA on Lemtrada...
www.finanznachrichten.de
Erin Pascal, or. Sanofi Investor Relations Sébastien Martel, +33 (0)
Press Room - Featured News
www.news.sanofi.us
Sanofi Genzyme Communications Contact Erin Pascal Tel.: + or. Sanofi Media Relations Contact
sortiert nach Relevanz / Datum